Traditional Chinese medicine for treating kidney essence deficiency syndrome type postmenopausal osteoporosis

Abstract

The invention discloses a traditional Chinese medicine for treating kidney essence deficiency syndrome type postmenopausal osteoporosis. The traditional Chinese medicine is characterized by being a traditional Chinese medicine preparation prepared from the following medicinal materials in parts by weight: 20-25 parts of caulis spatholobi, 25-30 parts of herba epimedii, 3-5 parts of deer-horn glue, 5-8 parts of yam rhizome, 25-30 parts of prepared rehmannia root, 15-20 parts of dogwood, 20-25 parts of the root of bidentate achyranthes, 12-15 parts of glossy privet fruit, 25-30 parts of albizia flower, 25-30 parts of medlar, 20-25 parts of fructus psoraleae, 10-12 parts of pomegranate bark and 10-12 parts of caltrop. The various raw materials are organically combined together, the components coordinate with one another and interact one another, and the traditional Chinese medicine can treat both symptoms and root causes of the kidney essence deficiency syndrome type postmenopausal osteoporosis with good effect and is used for radically treating the disease. For many years, according to statistics of follow-up survey of 50 patients, the cure rate of the prescription is 92 percent.

Description

Technical field [0001] The invention relates to a Chinese medicine, in particular to a Chinese medicine for treating osteoporosis in menopausal women with deficiency of kidney essence syndrome. Background technique [0002] Osteoporosis in postmenopausal women refers to a rapid decline in estrogen levels after menopause, leading to hyperabsorption, reduced bone mass, increased bone fragility, and a metabolic bone disease related to menopause that is prone to fracture. Primary osteoporosis. According to epidemiological surveys, about 1 / 3 of postmenopausal women suffer from osteoporosis, especially in the 3-4 years postmenopausal, the annual bone loss is about 2.7%, and then 1.7% in 1 year and 8-10 years. For the stable period, the present invention mainly studies osteoporosis in menopausal women before the age of 55, which urgently needs early prevention and early treatment. The occurrence of this disease is closely related to kidney deficiency. It can be divided into multiple s...

AI Technical Summary

Problems solved by technology

At present, Western medicine mostly takes calcium tablets to treat the disease, which treats the symptoms but not the root cause, and cannot treat the disease fundamentally. The majority of patients with this disease urgently need a drug that can treat both symptoms and root causes, has no dependence, and has no side effects.